Biomedical Engineering
Re-engineered autologous T cells attack non-Hodgkin lymphoma cells
Published in Gene Therapy Weekly, June 16th, 2005
"Adoptive immunotherapy with tumor-specific T cells is an emerging technology that may be applicable to a broad range of cancers. However, tumors can avoid T cell-mediated attack through multiple mechanisms, including downregulation of major histocompatability complex (MHC)," scientists in England report.
"Consequently, engineering T cells to target intact protein antigen directly, thus bypassing the need for MHC presentation, can facilitate T cell targeting of tumor cells," E.J. Cheadle and colleagues, Paterson Institute for Cancer Research, Cancer Research U.K., Department of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-06-16)
More Articles from Gene Therapy Weekly
- Gene Delivery
Stealth liposomes transport genes to breast cancer cells - Stem Cell Research
Genetically modified mesenchymal stem cells heal neurological disorders - Vector Development
Leaky tumor vessels allow systemic gene transfer after adenoviral transfection - Vector Development
Tick-borne encephalitis virus vector prolongs transgene expression - Acute Myeloid Leukemia
New findings in acute myeloid leukemia described - Alzheimer Disease
Gene therapy company licenses gene from university - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
